Nuclear chemistry summer school: A surprising new journey towards a rewarding career
Related Products
Increasing the availability of at-211: Investigating the chemical behavior after shipment
Interest in α-emitting radionuclides for applications in Targeted Alpha Therapy (TAT) continues to grow. With its relatively short half-life (~7.2 h) and its rather simple decay scheme, At-211 is one of the most advantageous nuclides for this purpose…
Exploring the chemistry of Astatine through the thermodynamics of liquid-liquid extraction systems
Astatine-211 is an isotope that possesses a short half-life of 7.2 hours, a high linear energy transfer, and a quantitative decay by α-emission (41.80% immediate, 58.20% ec)…
Automation of astatine recovery from nitric acid media
Targeted Alpha Therapy considers 211At as one of the most promising radionuclides. However, the short half-life (~7.2 h) and high medically relevant activities require development of an automated system for the astatine isolation and purification…
Advancements in Bi targetry for 211at production
Astatine-211 is an interesting isotope for targeted alpha therapy (TAT) cancer research given its short half-life and simple decay pathway. It is most often produced via the 209Bi(α,2n)211At using a 28…